Remifentanil for Smooth Emergence in Elderly Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Drug Usage
Interventions
DRUG

Remifentanil

Remifentanil was maintained at predetermined effect-site concentration during the periextubation period (initial concentration: 1.8 ng/ml) in elderly patients (65-80 years) .

DRUG

Remifentanil

Remifentanil was maintained at predetermined effect-site concentration during the periextubation period (initial concentration: 1.8 ng/ml) in adult patients (20-60 years) .

DRUG

Sevoflurane

Anesthesia was maintained with sevoflurane with 1.5-2.0 vol% in air/50%oxygen mixture, and sevoflurane was adjusted to about 1.0 vol% 10 min before end of surgery.

Trial Locations (1)

443-721

Ajou University Hospital, Suwon

All Listed Sponsors
lead

Ajou University School of Medicine

OTHER

NCT02334046 - Remifentanil for Smooth Emergence in Elderly Patients | Biotech Hunter | Biotech Hunter